Prosperity Consulting Group’s iShares US Medical Devices ETF IHI Stock Holding History

Prosperity Consulting Group’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$308K	Sell	6,226 -1,131	-15%	-$57.4K	0.01%	483
2026 Q1	$392K	Sell	7,357 -3,547	-33%	-$208K	0.02%	388
2025 Q4	$678K	Sell	10,904 -728	-6%	-$44.9K	0.03%	310
2025 Q3	$699K	Buy	11,632 +135	+1%	+$8.26K	0.03%	294
2025 Q2	$720K	Sell	11,497 -826	-7%	-$49.6K	0.05%	265
2025 Q1	$742K	Buy	12,323 +327	+3%	+$20.3K	0.06%	254
2024 Q4	$700K	Buy	11,996 +1,123	+10%	+$66.7K	0.05%	267
2024 Q3	$644K	Buy	+10,873	New	+$621K	0.05%	280

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Prosperity Consulting Group's IHI Position: Q2 2026 in Review

Prosperity Consulting Group reduced its iShares US Medical Devices ETF (IHI) stake by 15% in Q2 2026, selling an estimated $57.4K and leaving 6,226 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #483.

Prosperity Consulting Group first reported a position in IHI in Q3 2024 and has held it in 8 quarters since. The position peaked at $742K in Q1 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Prosperity Consulting Group held 6,226 shares of iShares US Medical Devices ETF worth $308K as of Q2 2026.
Prosperity Consulting Group sold 1,131 iShares US Medical Devices ETF shares in Q2 2026, an estimated $57.4K.
iShares US Medical Devices ETF made up 0.01% of Prosperity Consulting Group's portfolio in Q2 2026, its #483 holding.
Prosperity Consulting Group first reported a position in iShares US Medical Devices ETF in Q3 2024 and has held it in 8 quarters since.
Prosperity Consulting Group's iShares US Medical Devices ETF position peaked at $742K in Q1 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.